BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lopes MA, Oliveira ECS, Quaglio AEV, Santos A, Imbrizi M, Mendes LER, Beraldo RF, Baima JP, Spiller AL, Magro DO, Sassaki LY. From gut to liver: Exploring the relationship between inflammatory bowel disease and metabolic dysfunction-associated steatotic liver disease. World J Hepatol 2025; 17(9): 109035 [PMID: 41024868 DOI: 10.4254/wjh.v17.i9.109035]
URL: https://www.wjgnet.com/1007-9327/full/v17/i9/109035.htm
Number Citing Articles
1
Ali Abdulla, Ayan M. Sheikhnoor, Kevin Ferrao, Lucy I. Stiles, Kosha J. Mehta. Bidirectional interplay between gut and liver in inflammatory bowel disease and hepatobiliary conditionsClinical and Experimental Medicine 2026;  doi: 10.1007/s10238-026-02102-w
2
Fotios Fousekis, Afroditi Lamprou, Maria Saridi, Ioanna Nefeli Mastorogianni, Konstantinos Mpakogiannis, Georgios D. Lianos, Konstantinos H. Katsanos. Metabolic Disorders and Inflammatory Bowel Diseases: Unraveling Shared Pathways and Clinical InteractionsMetabolites 2026; 16(3): 181 doi: 10.3390/metabo16030181
3
Cheng Chang, Xiaolan Hu, Qimao Hu, Anrui Zheng. The role of ulcerative colitis-associated genes in the prognosis, immune cell infiltration, and immunotherapy efficacy of hepatocellular carcinomaEuropean Journal of Medical Research 2026;  doi: 10.1186/s40001-026-04283-2